Journal article
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6
Abstract
Anticoagulant therapy is widely used for the management of acute coronary syndromes. In order to optimize patient outcomes, anticoagulants should ideally combine high antithrombotic efficacy with a low risk of bleeding. Intravenous unfractionated heparin has been in clinical use for more than 50 years and reduces the risk of recurrent ischemic events in patients with acute coronary syndromes but at the cost of increased bleeding. Enoxaparin, …
Authors
Karthikeyan G; Mehta SR; Eikelboom JW
Journal
Expert Review of Cardiovascular Therapy, Vol. 7, No. 3, pp. 241–249
Publisher
Taylor & Francis
Publication Date
March 2009
DOI
10.1586/14779072.7.3.241
ISSN
1477-9072